Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: The potential role of N7-methylguanosine (m7G) in cancer

Fig. 2

The cross talk between m7G modification and other posttranscriptional modifications. The m6Am methyltransferase PCIF1 catalyzes m6Am modification adjacent to the m7G cap, which enhances resistance to DCP2-dominated decapping. The m6Am methyltransferase METTL14 installs m6Am modification at an internal site in U2 snRNA, ultimately influencing global alternative RNA splicing

Back to article page